Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2021

Open Access 01-12-2021 | Influenza Virus | Research article

Anti-influenza A virus activity of two Newtonia species and the isolated compound myricetin-3-o-rhamnoside

Authors: Katlego E. Motlhatlego, Parvaneh Mehrbod, Fatemeh Fotouhi, Muna Ali Abdalla, Jacobus N. Eloff, Lyndy J. McGaw

Published in: BMC Complementary Medicine and Therapies | Issue 1/2021

Login to get access

Abstract

Background

Some viruses play a key role in the disturbance of the digestive system. The common viruses which cause infectious diarrhoea (gastroenteritis) include astrovirus, caliciviruses, coronavirus and torovirus which are single-stranded RNA viruses. Influenza A virus (H1N1) also causes diarrhoea in addition to being associated with respiratory symptoms. In preliminary studies, Newtonia hildebrandtii and N. buchananii leaf extracts had good antibacterial activity against some bacteria implicated in causing diarrhoea. The aim of this study was to evaluate the anti-influenza activity of two Newtonia species extracts and the isolated compound (myricitrin).

Methods

N. hildebrandtii and N. buchananii acetone, and MeOH: DCM (methanol-dichloromethane) leaf and stem extracts, and an antibacterial compound myricetin-3-o-rhamnoside (myricitrin), isolated from N. buchananii, were evaluated for their antiviral efficacy against influenza A virus (IAV) PR8/34/H1N1 as a model organism. The MTT and hemagglutination assays were used to assess the extracts and compound interference with cell viability and viral surface HA glycoprotein. The quantitative real-time PCR was performed to assess the viral load.

Results

Plant extracts of N. hildebrandtii and N. buchananii were effective against IAV. The extracts in combination with H1N1 showed highly significant antiviral activity (P < 0.01) and maintained cell viabilities (P < 0.05). Myricitrin was non-cytotoxic at concentration 104 μg/ml. Myricitrin was most effective against IAV in a co-penetration combined treatment, thereby confirming the inhibitory effect of this compound in the viral attachment and entry stages. Myricitrin treatment also resulted in the highest viability of the cells in co-penetration treatment. The activity of myricitrin indicates the potential of the extracts in controlling viral infection at the attachment stage. The antiviral effect of myricitrin on IAV load in MDCK cell culture was confirmed using quantitative real-time PCR.

Conclusion

Data from this study support further research and development on Newtonia hildebrandtii, Newtonia buchananii and myricitrin to address diarrhoea and related conditions caused by viruses in both human and veterinary medicine. Further work needs to be conducted on the activity of the extracts and the purified compound on other viruses of importance which have similar symptoms to influenza virus such as the coronavirus which led to a recent global pandemic.
Literature
1.
go back to reference Arora R, Chawla R, Marwah R, Arora P, Sharma R, Kaushik V, et al. Potential of complementary and alternative medicine in preventive management of novel H1N1 flu (swine flu) pandemic: thwarting potential disasters in the bud. Evid-Based Compl Alt. 2011;2011:1–16.CrossRef Arora R, Chawla R, Marwah R, Arora P, Sharma R, Kaushik V, et al. Potential of complementary and alternative medicine in preventive management of novel H1N1 flu (swine flu) pandemic: thwarting potential disasters in the bud. Evid-Based Compl Alt. 2011;2011:1–16.CrossRef
2.
go back to reference Rehman A, Ahluwalia J. Viral infections in immunocompetent patients: A case series of HSV and CMV gastrointestinal infections. Am J Gastroenterol. 2011:471. Rehman A, Ahluwalia J. Viral infections in immunocompetent patients: A case series of HSV and CMV gastrointestinal infections. Am J Gastroenterol. 2011:471.
3.
go back to reference Goodgame RW. Viral infections of the gastrointestinal tract. Curr Gastroenterol Report. 1999;1:292–300.CrossRef Goodgame RW. Viral infections of the gastrointestinal tract. Curr Gastroenterol Report. 1999;1:292–300.CrossRef
4.
go back to reference Goodgame RW. Viral causes of diarrhea. Gastroenterol Clin. 2001;30:779–95.CrossRef Goodgame RW. Viral causes of diarrhea. Gastroenterol Clin. 2001;30:779–95.CrossRef
5.
go back to reference Riquelme A, Alvarez-Lobos M, Pavez C, Hasbun P, Dabanch J, Cofre C, et al. Gastrointestinal manifestations among Chilean patients infected with novel influenza a (H1N1) 2009 virus. Gut. 2009;58:1567–8.CrossRef Riquelme A, Alvarez-Lobos M, Pavez C, Hasbun P, Dabanch J, Cofre C, et al. Gastrointestinal manifestations among Chilean patients infected with novel influenza a (H1N1) 2009 virus. Gut. 2009;58:1567–8.CrossRef
6.
go back to reference Matsui SM, Angel J. Viral infections of the gastrointestinal tract. Curr Opin Gastroenterol. 1997;13:57–63.CrossRef Matsui SM, Angel J. Viral infections of the gastrointestinal tract. Curr Opin Gastroenterol. 1997;13:57–63.CrossRef
7.
go back to reference Shaw RD. Viral infections of the gastrointestinal tract. Curr Opin Gastroenterol. 2000;16:12–7.CrossRef Shaw RD. Viral infections of the gastrointestinal tract. Curr Opin Gastroenterol. 2000;16:12–7.CrossRef
8.
go back to reference Anderson EJ. Prevention and treatment of viral diarrhea in pediatrics. Expert Rev Anti-Infe. 2010;8:205–17.CrossRef Anderson EJ. Prevention and treatment of viral diarrhea in pediatrics. Expert Rev Anti-Infe. 2010;8:205–17.CrossRef
9.
go back to reference Moore NE, Wang J, Hewitt J, Croucher D, Williamson DA, Paine S, et al. Metagenomic analysis of viruses in feces from unsolved outbreaks of gastroenteritis in humans. J Clin Microb. 2014;35:15–21. Moore NE, Wang J, Hewitt J, Croucher D, Williamson DA, Paine S, et al. Metagenomic analysis of viruses in feces from unsolved outbreaks of gastroenteritis in humans. J Clin Microb. 2014;35:15–21.
10.
go back to reference Higgins RR, Beniprashad M, Cardona M, Masney S, Low DE, Gubbay JB. Evaluation and verification of the Seeplex® diarrhea-V ACE assay for the simultaneous detection of adenovirus, rotavirus and Norovirus genogroups I and II in clinical stool specimens. J Clin Microb. 2011;49:3154–62.CrossRef Higgins RR, Beniprashad M, Cardona M, Masney S, Low DE, Gubbay JB. Evaluation and verification of the Seeplex® diarrhea-V ACE assay for the simultaneous detection of adenovirus, rotavirus and Norovirus genogroups I and II in clinical stool specimens. J Clin Microb. 2011;49:3154–62.CrossRef
11.
go back to reference Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26:D49–53.CrossRef Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26:D49–53.CrossRef
12.
go back to reference Parimala Devi B, Manoharan K. Anti viral medicinal plants - an ethnobotanical approach. J Phytol. 2009;1. Parimala Devi B, Manoharan K. Anti viral medicinal plants - an ethnobotanical approach. J Phytol. 2009;1.
13.
go back to reference Minodier L, Charrel RN, Ceccaldi P-E, Van Der Werf S, Blanchon T, Hanslik T, et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J. 2015;12:215.CrossRef Minodier L, Charrel RN, Ceccaldi P-E, Van Der Werf S, Blanchon T, Hanslik T, et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J. 2015;12:215.CrossRef
14.
go back to reference Wang J, Li F, Wei H, Lian Z-X, Sun R, Tian Z. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell–dependent inflammation. J Expe Med. 2014;211:2397–410.CrossRef Wang J, Li F, Wei H, Lian Z-X, Sun R, Tian Z. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell–dependent inflammation. J Expe Med. 2014;211:2397–410.CrossRef
15.
go back to reference de Jong MD, Cam BV, Qui PT, Hien VM, Thanh TT, Hue NB, et al. Fatal avian influenza a (H5N1) in a child presenting with diarrhea followed by coma. New Engl J Med. 2005;352:686–91.CrossRef de Jong MD, Cam BV, Qui PT, Hien VM, Thanh TT, Hue NB, et al. Fatal avian influenza a (H5N1) in a child presenting with diarrhea followed by coma. New Engl J Med. 2005;352:686–91.CrossRef
16.
go back to reference Wiwanitkit V. Diarrhoea as a presentation of bird flu infection: a summary on its correlation to outcome in Thai cases. Gut. 2005;54:1506.CrossRef Wiwanitkit V. Diarrhoea as a presentation of bird flu infection: a summary on its correlation to outcome in Thai cases. Gut. 2005;54:1506.CrossRef
17.
go back to reference Deriu E, Boxx GM, He X, Pan C, Benavidez SD, Cen L, et al. Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through type I interferons. PLoS Pathog. 2016;12:e1005572.CrossRef Deriu E, Boxx GM, He X, Pan C, Benavidez SD, Cen L, et al. Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through type I interferons. PLoS Pathog. 2016;12:e1005572.CrossRef
18.
go back to reference Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet. 2000;355:827–35.CrossRef Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet. 2000;355:827–35.CrossRef
19.
go back to reference Tran TT, Kim M, Jang Y, Lee HW, Nguyen HT, Nguyen TN, et al. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense. BMC Complem Altern Med. 2017;17:162.CrossRef Tran TT, Kim M, Jang Y, Lee HW, Nguyen HT, Nguyen TN, et al. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense. BMC Complem Altern Med. 2017;17:162.CrossRef
20.
go back to reference Hwang BS, Lee I-K, Choi HJ, Yun B-S. Anti-influenza activities of polyphenols from the medicinal mushroom Phellinus baumii. Bioorg Med Chem Lett. 2015;25:3256–60.CrossRef Hwang BS, Lee I-K, Choi HJ, Yun B-S. Anti-influenza activities of polyphenols from the medicinal mushroom Phellinus baumii. Bioorg Med Chem Lett. 2015;25:3256–60.CrossRef
21.
go back to reference Rajasekaran D, Palombo EA, Yeo TC, Ley DLS, Tu CL, Malherbe F, et al. Identification of traditional medicinal plant extracts with novel anti-influenza activity. PLoS One. 2013;8:e79293.CrossRef Rajasekaran D, Palombo EA, Yeo TC, Ley DLS, Tu CL, Malherbe F, et al. Identification of traditional medicinal plant extracts with novel anti-influenza activity. PLoS One. 2013;8:e79293.CrossRef
22.
go back to reference Motlhatlego K, Njoya EM, Abdalla MA, Eloff JN, McGaw LJ. The potential use of leaf extracts of two Newtonia (Fabaceae) species to treat diarrhoea. S Afr J Bot. 2018;116:25–33.CrossRef Motlhatlego K, Njoya EM, Abdalla MA, Eloff JN, McGaw LJ. The potential use of leaf extracts of two Newtonia (Fabaceae) species to treat diarrhoea. S Afr J Bot. 2018;116:25–33.CrossRef
23.
go back to reference Motlhatlego K, Abdalla M, Leonard C, Eloff J, McGaw L. Inhibitory effect of Newtonia extracts and myricetin-3-O-rhamnoside (myricitrin) on bacterial biofilm formation. BMC Complem Altern Med. 2020;20:1–10.CrossRef Motlhatlego K, Abdalla M, Leonard C, Eloff J, McGaw L. Inhibitory effect of Newtonia extracts and myricetin-3-O-rhamnoside (myricitrin) on bacterial biofilm formation. BMC Complem Altern Med. 2020;20:1–10.CrossRef
24.
go back to reference Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.CrossRef Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.CrossRef
25.
go back to reference Mehrbod P, Motamed N, Tabatabaian M, Estyar RS, Amini E, Shahidi M, et al. In vitro antiviral effect of "Nanosilver" on influenza virus. DARU. 2009;17:88–93. Mehrbod P, Motamed N, Tabatabaian M, Estyar RS, Amini E, Shahidi M, et al. In vitro antiviral effect of "Nanosilver" on influenza virus. DARU. 2009;17:88–93.
26.
go back to reference Karber G. 50% end point calculation. Arch Exp Pathol Phar. 1931;162:480–3.CrossRef Karber G. 50% end point calculation. Arch Exp Pathol Phar. 1931;162:480–3.CrossRef
27.
go back to reference Chattopadhyay D, Chawla-Sarkar M, Chatterjee T, Dey RS, Bag P, Chakraborti S, et al. Recent advancements for the evaluation of anti-viral activities of natural products. New Biotechnol. 2009;25:347–68.CrossRef Chattopadhyay D, Chawla-Sarkar M, Chatterjee T, Dey RS, Bag P, Chakraborti S, et al. Recent advancements for the evaluation of anti-viral activities of natural products. New Biotechnol. 2009;25:347–68.CrossRef
28.
go back to reference Godornes C, Leader BT, Molini BJ, Centurion-Lara A, Lukehart SA. Quantitation of rabbit cytokine mRNA by real-time RT-PCR. Cytokine. 2007;38:1–7.CrossRef Godornes C, Leader BT, Molini BJ, Centurion-Lara A, Lukehart SA. Quantitation of rabbit cytokine mRNA by real-time RT-PCR. Cytokine. 2007;38:1–7.CrossRef
29.
go back to reference Amic D, Amie DD, Beslo D, Trinajstic N. Structural-radical scavenging activity relationship of flavonoids. Croat Chem Acta. 2003;76:55–61. Amic D, Amie DD, Beslo D, Trinajstic N. Structural-radical scavenging activity relationship of flavonoids. Croat Chem Acta. 2003;76:55–61.
30.
go back to reference Aqil F, Ahmad I, Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turk J Biology. 2006;30:177–83. Aqil F, Ahmad I, Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turk J Biology. 2006;30:177–83.
31.
go back to reference Kaul TN, Middleton E Jr, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol. 1985;15:71–9.CrossRef Kaul TN, Middleton E Jr, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol. 1985;15:71–9.CrossRef
32.
go back to reference Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013:1–16. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013:1–16.
33.
go back to reference Zink T, Chaffin J. Herbal health products: what family physicians need to know. Am Fam Physician. 1998;58:1133–40.PubMed Zink T, Chaffin J. Herbal health products: what family physicians need to know. Am Fam Physician. 1998;58:1133–40.PubMed
34.
go back to reference Motlhatlego KE. The antimicrobial activity and safety of two Newtonia species with potential antidiarrhoeal effect. Pretoria: University of Pretoria; 2017. Motlhatlego KE. The antimicrobial activity and safety of two Newtonia species with potential antidiarrhoeal effect. Pretoria: University of Pretoria; 2017.
Metadata
Title
Anti-influenza A virus activity of two Newtonia species and the isolated compound myricetin-3-o-rhamnoside
Authors
Katlego E. Motlhatlego
Parvaneh Mehrbod
Fatemeh Fotouhi
Muna Ali Abdalla
Jacobus N. Eloff
Lyndy J. McGaw
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2021
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-021-03250-0

Other articles of this Issue 1/2021

BMC Complementary Medicine and Therapies 1/2021 Go to the issue